Clinical Trial Update: A Pilot Study of Chronic Red Blood Cell Transfusion in Sickle Cell Disease-Associated Pulmonary Hypertension [Phase 2]

View source ↗

Summary

Phase 2 pilot trial evaluating chronic red blood cell transfusions for sickle cell disease–associated pulmonary hypertension has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension
• Sickle Cell Disease

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Pulmonary Hypertension, Sickle Cell Disease | Phase 2 | Status: WITHDRAWN